GICS sector
Health Care.
Pharmaceuticals, biotech, devices, and health services. The 25 largest names by market capitalization, with fundamentals from SEC filings and the nightly screener refresh.
| # | Company | Market cap | P/E | Net margin | Rev growth | Div yield |
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly and Company | $1.05T | 41.5 | 35.0% | 55.5% | 0.6% |
| 2 | JNJJohnson & Johnson | $609.1B | 29.0 | 21.5% | 6.6% | 2.1% |
| 3 | ABBVAbbVie Inc. | $449.6B | 124.8 | 5.8% | 12.4% | 2.7% |
| 4 | UNHUnitedHealth Group Incorporated | $387.0B | 31.8 | 2.7% | 2.0% | 2.2% |
| 5 | RHHBYRoche Holding Ltd | $343.6B | — | — | — | — |
| 6 | MRKMerck & Company, Inc. | $314.9B | 36.0 | 13.6% | 4.9% | 2.7% |
| 7 | AZNAstraZeneca PLC | $290.1B | — | — | — | — |
| 8 | NVSNovartis AG | $290.0B | — | — | — | — |
| 9 | NVONovo Nordisk A/S | $199.3B | — | — | — | — |
| 10 | TMOThermo Fisher Scientific Inc | $197.9B | 29.8 | 15.2% | 6.2% | 0.4% |
| 11 | AMGNAmgen Inc. | $197.7B | 25.8 | 21.0% | 5.8% | 2.8% |
| 12 | ABTAbbott Laboratories | $175.4B | 27.7 | 13.9% | 7.8% | 2.5% |
| 13 | GILDGilead Sciences, Inc. | $166.7B | 18.5 | 31.0% | 4.4% | 2.4% |
| 14 | DHRDanaher Corporation | $144.3B | 39.7 | 14.9% | 3.7% | 0.8% |
| 15 | PFEPfizer, Inc. | $142.8B | 19.1 | 11.8% | 5.4% | 6.9% |
| 16 | CVSCVS Health Corporation | $137.1B | 46.7 | 0.7% | 6.1% | 2.5% |
| 17 | BMYBristol-Myers Squibb Company | $124.0B | 17.0 | 15.0% | 2.6% | 4.1% |
| 18 | VRTXVertex Pharmaceuticals Incorpor | $123.3B | 28.8 | 35.5% | 7.8% | 0.0% |
| 19 | SYKStryker Corporation | $122.6B | 38.3 | 13.2% | 2.6% | 1.1% |
| 20 | ISRGIntuitive Surgical, Inc. | $122.3B | 46.1 | 28.4% | 18.5% | 0.0% |
| 21 | MDTMedtronic plc. | $106.5B | 22.4 | 13.2% | 9.9% | 3.5% |
| 22 | SNYSanofi | $105.9B | — | — | — | — |
| 23 | GLAXFGSK plc | $104.3B | — | — | — | — |
| 24 | GSKGSK plc | $103.1B | — | — | — | — |
| 25 | MCKMcKesson Corporation | $98.5B | 21.9 | 1.2% | 6.0% | 0.4% |
Fundamentals refreshed nightly from SEC EDGAR filings and the screener store. Missing values shown as em-dashes, never estimated.
Head-to-head in health care
ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comFundamentals parsed first-hand from SEC EDGAR filings · Constituents ranked by market capitalization · refreshed nightly
Screen every health care stock in the terminal
Filter by 60+ fundamentals, ALAN scores, and custom rules — free account, no card.
For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.